Takeaways from the 3rd Antibody-Drug Conjugate (ADC) Toxicity Summit
Year: 2025
Type: article
Abstract: The 3rd Antibody-Drug Conjugate (ADC) in Boston, MA, brought together a group of diverse yet deeply specialized experts who shared their knowledge, clinical insights, and technical experience with remarkable openness and clarity. The focus of the summit was on toxicities associated with Antibody-Drug Conjugates, a class of targeted cancer therapies that have shown great promise but also present challenges — especially in terms of off-target effects and patient safety.
Author: Sonia Jain
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4413765415